Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

ST Louis, Missouri 63110


Purpose:

The primary objective of this project is to investigate the effect of statin therapy on cerebral blood flow in patients with aneurysmal SAH who are randomized to receive or not receive statins in a blinded design.


Study summary:

We will determine if statin therapy improves CBF in patients with aneurysmal subarachnoid hemorrhage. This improvement, if present, may be due to improved basal CBF, improved autoregulatory function, or a mitigation of large arterial narrowing. The information gain from this study will help us to better understand the mechanism of action of statins. This knowledge may be useful in the design of future studies with statins and in the development of other therapies aimed at similar mechanisms.


Criteria:

Inclusion Criteria: - Age > 18 - SAH from ruptured cerebral aneurysm within 48 hours of admission. - Modified Fisher grade 2,3,or 4 - Planned surgical or endovascular aneurysm repair Exclusion Criteria: - Pregnancy - SAH secondary to traumatic or mycotic aneurysms - Pre-ictal statin therapy - Contraindication to stain therapy - WFNS grade 5 - Contraindications to MAP elevation on day 7-10


NCT ID:

NCT00795288


Primary Contact:

Principal Investigator
Michael Diringer, MD
Washington University


Backup Contact:

N/A


Location Contact:

ST Louis, Missouri 63110
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.